Riskpilot← Back to searchSign inGet full accessDerma Vision AB
ABActiveOrg 5592683287Krysshammarvägen 42Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2024
SEK 240K
+68% vs 2023
EBITDA margin
46.8%
+523% vs 2023
Equity ratio
69.0%
Financial strength
Net profit 2024
SEK 98K
+469% vs 2023
| Revenue | SEK 240K | +68% |
| EBITDA | SEK 113K | +523% |
| Net profit | SEK 98K | +469% |
| Total assets | SEK 249K | +96% |
| Equity | SEK 172K | +133% |
| Employees | 0 | — |
Legal name
Derma Vision AB
Org number
5592683287
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 augusti 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk vård, inom oftalmologi, dermatologi, allmänmedicin samt estetiska injektioner och behandlingar. Den medicinska vården bedrivs till exempel genom konsultläkartjänster inom öppen- såväl som slutenvård för nämnda specialiteter.
Address
Krysshammarvägen 42
Email
dermavisionab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 146 | 223 | 143 | 240 |
| Staff expenses | — | — | −0 | −0 |
| EBITDA | 16 | 79 | −27 | 113 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 16 | 79 | −27 | 113 |
| Net financials | — | −0 | 0 | −0 |
| Profit before tax | 15 | 79 | −27 | 112 |
| Tax | −3 | −16 | −0 | −14 |
| Net profit | 12 | 63 | −27 | 98 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 101 | 203 | 127 | 249 |
| Equity | 37 | 100 | 74 | 172 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 64 | 102 | 53 | 77 |
| Total debt | 64 | 102 | 53 | 77 |
EBITDA margin
46.8%
This company
15.8%
Market median
+196% vs market
20212024
Equity ratio
69.0%
This company
38.2%
Market median
+81% vs market
20212024
Return on equity
57.1%
This company
18.4%
Market median
+210% vs market
20212024
Net profit margin
40.8%
This company
8.1%
Market median
+404% vs market
20212024
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20212024
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Derma Vision AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alan Celiker | Deputy Board Member | 0 companies |
| Celadet Celiker | Deputy Board Member | 0 companies |
| Evin Celiker | Board of Directors | 0 companies |
| Kawa Tekantape | Board of Directors | 0 companies |